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Abstract: Toll-like receptors (TLRs) recognise pathogen-associated molecular patterns (PAMPs) derived from 
pathogens and participate in activation of the immune responses. The TLR2 gene can recognise PAMPs 
specific to bacterial diseases such as pneumonia. In the present study, we sequenced the coding regions 
of the TLR2  gene in 18  rabbits from 5 breeds, including New Zealand White, Californian, Flemish Giant, 
Chinchilla and Fu Jian Yellow. In total, we discovered 11 single nucleotide polymorphisms (SNPs), including 
4 non-synonymous SNPs located within the predicted TLR domains. Two non-synonymous SNPs (G205A 
and G265C) were located in the LRR (leucine-rich repeat) domains of the predicted protein, while another 
non-synonymous SNP (C943T) was situated in the regions involved in binding to ligands. In addition, one 
synonymous SNP (C1174T) was distributed in the nucleus regions of heterodimers formed. Then, we 
revealed five conservative regions in the LRR patterning by prediction and comparison of TLR2  protein 
domain architectures for multiple species. The SNPs in the TLR2  gene may increase the probability of 
adaptation to variability of PAMPs due to the rapid evolution of pathogens and the possibility of survival 
in rabbit populations. The SNPs reported here will be useful to investigate the association between the 
TLR2 gene and disease resistance in future studies.
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intRoDuction
A major challenge to the application of selection for resistance to disease is the exposure to pathogens. Challenging 
breeding animals is generally impracticable and cannot guarantee the animals’ welfare. Therefore, identification of 
DNA markers for disease resistance is widely studied and many useful single nucleotide polymorphisms (SNPs) are 
reported (Nicholas, 2005). Testing candidate genes is an approach used to search for DNA markers. In terms of innate 
immune system, pattern recognition receptors specifically recognise the molecular patterns derived from pathogens. 
Toll-like receptors (TLRs) play important roles in recognising “pathogen-associated molecular patterns (PAMPs)” 
of pathogens (such as viruses, bacteria and fungi; Abreu et al., 2010). They may also initiate the early immune 
response in both innate and acquired immunity (Vasselon and Detmers, 2002). Mammalian TLR proteins contain 
an extracellular domain that consists of leucine-rich repeat (LRR) domains and an intracellular region that consists 
of a Toll/IL-1 receptor (TIR/IL-1R). The LRR domains are involved in ligand recognition and the TIR/IL-1R mediates 
signal transduction. TLR2 recognises PAMPs which are specific to microbes (Akira and Takeda, 2004). TLR2 could 
identify mycobacterial lipoglycan and other bacterial cell wall macroamphiphiles (Ray et al., 2013). As a result, it is 
reasonable to consider that TLR2 is a critical candidate gene for studies of resistance or susceptibility to bacterial 
infection in rabbits. It is well known that nucleotide change of the TLR genes may affect their ability to recognise 
PAMPs (Uenishi and Shinkai, 2009). Previous studies have demonstrated that the TLR genes could recognise slight 
differences among PAMPs (Janeway and Medzhitov, 2002). We can hypothesise that the sensitive recognition ability 
is due to polymorphisms in TLRs. Furthermore, many studies of TLR genes have revealed an association between 
polymorphisms in the TLR genes and disease (Bochud et  al., 2007; He et  al., 2007; Abu-Amero et  al., 2013). 
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Polymorphisms in the human TLR2 gene protect against malaria (Greene et al., 2012). The Arg753Gln mutation in 
the human TLR2 gene is associated with vitiligo susceptibility and urinary tract infection (Tabel et al., 2007; Karaca 
et  al., 2013). A16934T polymorphism in the human TLR2  gene is associated with severity of atopic dermatitis 
(Potaczek et al., 2011). In this study, we sequenced 18 rabbits from 5 breeds to discover genetic polymorphisms 
in the TLR2 gene. SNPs, especially non-synonymous SNPs, discovered in this study will be useful to investigate the 
association of TLR2 in disease resistance in future studies.
matERialS anD mEthoDS
DnA samples and extraction
The blood samples were collected from 18 buck rabbits of different breeds from different breeding farms. In addition 
to 6 Flemish Giant rabbits, there were 3 rabbits from other breeds. The DNA extracted from the muscle of a New 
Zealand White buck was used to conduct the confirmation of amplification products by basic local alignment search 
tool (BLAST) and optimise amplification conditions (Seabury et al., 2007). DNA samples used for inspection were 
obtained from 5 breeds (New Zealand White, Californian, Flemish Giant, Chinchilla and Fu Jian Yellow) and stored 
at –20 °C after being extracted from whole-venous blood. These 5 breeds are the main types most widely used in 
production in China. Genomic DNA was extracted by using a Universal Genomic DNA Extraction Kit (TaKaRa, Dalian, 
China) according to the manufacturer’s instructions.
pCr and sequencing
The entire coding sequence (CDS) of the TLR2 gene (NM_001082781) was used to design the polymerase chain 
reaction (PCR) primers. Seven PCR primer pairs that produced overlapping fragments were designed according to 
the entire coding sequence (CDS) of the TLR2 gene by using the Web interface for Primer 3 (http://frodo.wi.mit.edu/
primer3) (Table 1). PCR reactions were performed in a volume of 25 μL consisting of the following: 50-100 ng g DNA, 
0.4 μM each primer (forward and reverse), 2×Taq PCR MasterMix (Tiangen, Beijin, China). A biomet thermocycler 
was used to amplify the DNA fragments in the following thermal conditions: 3 min at 94 °C; 30 cycles×30 s at 94 °C, 
30 s at 55 °C, and 1 min at 72 °C; 5 min at 72 °C. The thermal cycling parameters of Primer 4 were the same as 
the above conditions except for annealing temperature, which was set to 58 °C.
All PCR amplicons were visualised via agarose electrophoresis and subsequently purified using the QIAquick PCR 
Purification Kit (Qiagen, Inc., Valencia, CA, USA), following the manufacturer’s recommendations. The PCR amplicons 
purified were sequenced using BigDye® Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, CA, 
USA) and an ABI 3730XL sequencer (Applied Biosystems, Foster City, CA, USA).
Detection of polymorphisms 
Data from automated sequencers may generally include miscalled bases at each side of the sequence. Sequence 
quality was evaluated by Sequencher4.7 (Gene Codes, Ann Arbor, MI, USA). Then, the low quality data at the ends 
of the sequence were trimmed by Sequencher4.7. Each sequence from a single DNA sample was assembled to 
generate a consensus sequence for that DNA sample and detect polymorphisms within the sample. The SNPs 
table 1: PCR primers for amplification of rabbit TLR2.
Fragment No. Forward primer(5'-3') Reverse primer(5'-3') Expected fragment size (bp)
1 aggttggatccctggacaat acagagatgtctccccaagg 451
2 gcctctctcgtccctgaaat tcaggcacataagccagaag 471
3 ggaagcctttatgcctttgc ttctcgcaggctgaattttt 683
4 aaagggtgaagagggtcaca aaagacaggaagtcgcagga 625
5 agcagctcgaatcctttcag gagttctccagctcctgcac 448
6 tcctgcgacttcctgtcttt gcgtcgttgttctcatcaaa 581
7 catcgactgcatcgagaaga accagttgcacagagacgtg 639
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were automatically detected using Sequencher4.7 and each of them was verified by manual identification based on 
chromatograms. All heterozygous nucleotides were presented by the appropriate IUPAC-IUB code. Database searches 
were conducted using the NCBI (National Center for Biotechnology Information) Web site and the oryCun2  rabbit 
genome assembly (May 2010). Additionally, DNAMAN version 5.0  software package (Lynnon Corporation) was 
applied to perform the alignments of TLR2 CDS and protein sequence of mammals.  
TLR protein domain architectures were predicted and compared by the online utility SMART (http://smart.embl-
heidelberg.de/) (Letunic et al., 2012). For all protein domain searches and predictions, the normal mode of simple 
modular architecture research tool (SMART) was used with the following settings: include PFAM domains, signal 
peptides, and internal repeats. SMART was also used to reveal how predicted amino acid replacements influence the 
prediction of protein domain architectures for rabbit TLR2.
RESultS
polymorphisms detected
To identify nucleotide polymorphisms, we designed primer pairs that amplified reciprocally overlapping fragments. 
With these primers, 2723bp corresponding to rabbit TLR2 were detected for 5 rabbit breeds and compared with the 
matched rabbit TLR2 reference sequences (NM_001082781). 
SNPs of the rabbit TLR2  gene were identified by Sanger sequencing (Figure  1). We detected 11  SNPs, among 
which, 36% (n=4) were non-synonymous SNPs, 64% (n=7) were synonymous SNPs. Of the 11 SNPs, 91% (n=10) 
were transitions (A ↔ G; C ↔ T) and 9% (n=1) were transversions. A search of the published literatures on rabbit 
TLR2  indicated that 8 of the polymorphisms identified are reported here for the first time. Through comparison of 
the rabbit genome sequence with the published cDNA sequence (NM_001082781), 3 SNPs (T488C, T567C and 
G1479A) can be found, which coincide with the SNPs reported in this research. In fact, the rate of occurrence for 
non-synonymous and synonymous SNPs in the CDS was one every 589 bp and one every 336 bp, respectively. The 
genomic positions of all SNPs, major and minor allele frequencies, SNP genotypes and amino acid positions are also 
provided in Table 2. Two non-synonymous SNPs distributed in the major protein domains predicted for rabbit TLR2, 
with predicted amino acid replacements observed within the LRR domains (Figure 2). The non-synonymous SNPs 
in the LRR domains may obviously change the ability 
to recognise extracellular pathogens. One non-
synonymous SNP that changed the charges on the 
amino acids was identified at bases 265 in TLR2, and 
non-synonymous SNPs of this kind were also observed 
at other positions in the gene (Table 2). 
Comparative prediction of protein domain 
architectures
Oryctolagus cuniculus TLR2  sequences are highly 
homologous to sequences from other mammalian 
species (Table  3). Through comparative prediction 
of TLR2  protein domain architectures via SMART for 
O. cuniculus, B. Taurus, O. aries, C. familiaris, M. 
musculus, H. sapiens, R. norvegicus and S. scrofa, 
we revealed five clusters of LRR patterning that were 
conserved among all species investigated (Figure  3). 
Moreover, comparative protein domain analysis for 
TLR2  showed that C. familiaris and H. sapiens were 
the species for which low-complexity regions were not 
confidently predicted by SMART. Furthermore, predicted 
signal peptides and Toll-interleukin-1  resistance (TIR) 
Figure 1:  SNPs identified in the rabbit TLR2  gene. 
Partial chromatograms show the heterozygosity of 
SNPs in samples. Arrows indicate position of nucleotide 
mutations.
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domains for TLR2 of all species were examined. Notably, one predicted amino acid replacement (R315W) encoded by 
a nsSNP could regulate the presence or absence of a LRR protein domain for O. cuniculus during sequential SMART 
analyses (Figure 3). The LRR protein domain did not occur for the rabbit TLR2 reference sequence, which encoded 
R at amino acid position  315. The predicted protein domain architectures for TLR2  were similar for all species 
investigated, implying that TLR2 in mammals are similar in function.
table 2: Distribution of single nucleotide polymorphisms (SNPs) among 18 individuals from 5 rabbit breedsa.
Allelesb
Genomic 
positionc
Observed 
frequencies
Amino acid 
positiond
Amino 
acide Character (SNP genotype) rabbit breedf Domain
G/A 205 0.94/0.06 69 D/N Anionic/ Neutral (R)N, B LRRg
G/C 265 0.91/0.09 89 D/H Anionic/Cationic (S)N, B LRR
T/C 488 0.5/0.5 163 A/V Non-polar/Non-polar (Y)B, C, Fu, N, Ch None
T/C 567 0.5/0.5 189 Y/Y - (Y)B, C, Fu, N, Ch None
C/T 597 0.69/0.31 199 N/N - (Y)B, C, Fu, N, Ch None
C/T 943 0.69/0.31 315 R/W Cationic/Non-polar (Y)B, C, Fu, N, Ch None
T/C 1174 0.75/0.25 392 L/L - (Y)B, C, Fu, N LRR
C/T 1327 0.69/0.31 443 L/L - (Y)B, C, Fu, N, Ch None
G/A 1479 0.75/0.25 493 P/P - (R)B, C, Fu, N, Ch LRR
T/C 1707 0.69/0.31 569 H/H - (Y)B, C, Fu, N, Ch LRR
C/T 2043 0.64/0.36 681 P/P - (Y)B, C, Fu, Ch TIR
a B: Flemish Giant; C: Californian; Ch: Chinchilla; N: New Zealand White; Fu: Fu Jian Yellow. b Alleles are depicted as major allele/
minor allele, including the NM_001082781 allele depicted in underlined text. c Genomic position based on the first base of the start 
codon. d Amino acid position based on the start codon. e Amino acid(s) match with the major and minor alleles, with predicted amino 
acid replacements. D: Aspartic Acid; N: Asparagine; H: Histidine; A: Alanine; V: Valine; Y: Tyrosine; R: Arginine; W: Tryptophan; L: 
Leucine; P: Proline.  f All heterozygous SNPs were presented by the IUPAC codes. R: A or G; S: G or C; Y: C or T.  g Leucine-rich repeat.
Figure 2: Distribution of SNPs in rabbit TLR2  gene detected in the predicted protein structural domain. SMART-
predicted domains and protein regions are indicated as follows: signal peptides are indicated by small red boxes (1); 
low-complexity regions are indicated in pink  (2); leucine-rich repeats are depicted as LRR, LRR TYP, and LRRCT; 
vertical blue rectangles  (3) indicate the transmembrane domain; TIR indicates Toll–interleukin 1-resistance 
homologous domain. Taking the start codon of this gene as the initial position, positions of nucleotides are used to 
label the locations of SNPs. The positions of amino acids which take the change are labelled in brackets along with 
the number and residues of amino acids (Shinkai et al., 2006). A red arrow and red domain figure  (4) label the novel 
LRR domain predicted by SMART. 
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DiScuSSion
snps and conserved domains
The ectodomains of TLR molecules consist mainly of LRR domains, which are essential structures that distinguish 
PAMPs (Botos et al., 2011). Analysis of polymorphisms in the rabbit TLR2 gene indicates that SNPs within it are mainly 
located in the ectodomain encoding sequence. Comparisons of the SNP distribution in the TLR coding sequences of 
table 3: Homology rates between the coding regions and amino acid sequence of the TLR2 of mammals.   
Species
Common 
name
Accession number of 
GenBank
Homology(%) of 
coding regions
Homology(%) of amino 
acid sequence
Bos Taurus Cattle NM_174197 76.46 70.70
Ovis aries Sheep NM_001048231 76.21 70.70
Canis lupus familiaris Dog NM_001005264 76.25 70.83
Mus musculus Mouse NM_011905 71.84 69.43
Homo sapiens Human NM_003264 78.46 76.18
Rattus norvegicus Rat NM_198769 72.65 70.32
Sus scrofa Pig NM_213761 77.31 72.99
Figure 3:  Comparison of TLR2  predicted protein domain architectures in different species of mammals. Domain 
architectures were predicted by SMART. Amino acid reference sequences for all species were retrieved from GenBank 
(O. cuniculus NP_001076250, B. Taurus NP_776622, O. aries NP_001041696, C. familiaris NP_001005264, M. 
musculus NP_036035, H. sapiens NP_003255, R. norvegicus NP_942064 and S. S. scrofa NP_998926). The LRR 
conserved domains all species have are labelled by a black dash box (4). SMART-predicted domains and protein regions 
are demonstrated as follows: signal peptides are indicated by small red boxes (1); low-complexity regions are indicated 
in pink (2); leucine-rich repeats are depicted as LRR, LRR TYP, and LRRCT; vertical blue rectangles (3) indicate the 
transmembrane domain; TIR indicates Toll–interleukin 1-resistance homologous domain (Seabury et al., 2007).
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pigs, cattle and humans reveal that while the non-synonymous SNPs are mainly located in sequences encoding the 
ectodomain, sequences encoding the LRR domains are particularly rich in non-synonymous SNPs (White et al., 2003; 
Shinkai et al., 2006; Tapping et al., 2007). Two non-synonymous SNPs (G205A and G265C) and 2 synonymous SNPs 
(T1174C and G1479A) are located in the LRR domains of the predicted TLR2 protein sequence. The non-synonymous 
SNPs in the LRR domains may dramatically alter the ability of the molecule to identify extracellular pathogens (Fujita 
et  al., 2003). Furthermore, polymorphisms in the sequences encoding ectodomains that are involved in pattern 
recognition could improve recognition of the various kinds of PAMPs originating from rapidly evolving pathogens.
One study on the crystal structures of human and mouse TLR2-lipopeptide associations revealed that the N-terminal 
266-355 amino acids participate in ligand binding (Jin et al., 2007). The region of interest corresponds to positions 
798-1065  in the TLR2 coding sequence. Through comparison of the mRNA sequences of human, rat and rabbit 
homologues, we found that a non-synonymous SNP (C943T) is located in a region that may affect ligand binding. 
Non-synonymous SNPs within the region involved in ligand binding may change the specificity of ligands recognised 
by the TLR2 and TLR1/TLR6 heterodimers and increase the type of patterns recognised by the heterodimers, thereby 
affecting the survival of a population (Carrington et  al., 1999; Kruithof et  al., 2007). The nuclear regions of the 
heterodimer formed by TLR2 and TLR1 comprise amino acids 318-398 of the N terminus (corresponding nucleotides 
954-1194) (Jin et  al., 2007), while the critical domain where TLR2  interacts with TLR6  comprises amino acids 
318-404 (corresponding to nucleotides 954-1212) (Kang et al., 2009). One synonymous SNP (C1174T) is located 
in this domain. However, as it does not change the amino acid it is unlikely to affect the heterodimers. In contrast, 
non-synonymous SNPs that modify the amino acid polarity in rabbit TLR2 may affect ligand binding. Furthermore, 
amino acid substitutions that alter the amino acid polarity may also have an impact on host immune responses and 
resistance to disease (Shinkai et al., 2006). Three SNPs (G205A, G265C and C943T) that change the polarity of their 
corresponding amino acids are present in rabbit TLR2. G205A and G265C are located in the predicted LRR domains 
and may affect the function of rabbit TLR2; for example, its function in ligand recognition. 
Nucleotide sequence comparisons indicate that the rabbit TLR2 mRNA sequence shares a high degree of homology 
with sequences from other mammals. In addition, comparisons of the predicted mammalian protein domain 
architecture of TLR2 may reveal the conserved protein domains of the TLR2 gene in mammals and identify similarities 
and differences in the LRR domains. Sequence conservation analysis of the predicted protein structures shows that 
there are 5 conserved LRR domains in mammalian TLR2. Notably, the non-synonymous G265C SNP is located in 
one of the conserved domains. Further research on the function of the conserved LRR domains and SNPs in these 
regions should uncover the important role that the conserved LRR domains and SNPs play in protecting mammals 
from pathogen invasion. There are some discrepancies between our predictions about the TLR2 mammalian protein 
domains and those of Seabury and Womack (2008). The main reason for this could be that we have not made 
predictions about regions of intrinsic disorder in the protein. Additionally, we used version 7 of the SMART database, 
whereas Seabury and Womack (2008), used version 5.0. Version 7.0  has an upgraded genomic mode protein 
database (Letunic et  al., 2006; Letunic et  al., 2012). In conclusion, the non-synonymous SNPs located in LRR 
domains (especially conserved LRR domains) and/or the central regions of heterodimers that alter amino acid polarity 
may have biological significance. These SNPs can be used as candidates for future research. Although synonymous 
SNPs do not change the amino acid sequence of a protein, they may influence gene expression, or the three-
dimensional structure of the encoded protein (Sauna and Kimchi-Sarfaty, 2011; Brest et al., 2011). Therefore, the 
synonymous SNPs reported herein merit further attention 
potential associations
Nowadays, few reports on associations between the rabbit TLR2  gene and pathogens appear in the scientific 
literature. The abundance of rabbit TLR2 mRNA was shown to increase significantly in lungs infected by pneumonia, 
which is mainly caused by bacterial infections (Kajikawa et  al., 2005). Additionally, TLR2 mRNA expression was 
significantly increased in inflamed prostate tissue in humans (Vignozzi et al., 2012). A recent study reported that 
polymorphisms in the rodent TLR2  gene are associated with Borrelia infection in a wild bank vole population 
(Tschirren et al., 2013). TLR2 recognises a variety of molecules, such as the peptidoglycans and lipoteichoic acid 
derived from Gram-positive bacteria, glycosylphosphatidylinositol from Trypanosoma spp. and zymosan from yeast 
(Takeda and Akira, 2005). Moreover, TLR2  forms a heterodimer with TLR1 or TLR6  to recognise mycobacterial-
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derived triacylglyceride or diacylglyceride molecules (Krutzik et al., 2003). The TLR2/TLR1 heterodimer can identify 
the lipoproteins from mycobacteria and meningococci (West et  al., 2006). Likewise, the TLR2/TLR6 heterodimer 
can recognise lipoprotein, peptidoglycan and Bacillus anthracis from mycoplasma, protozoa and fungi, respectively 
(Takeuchi et al., 2001). Bacterial infections such as pneumonia present major challenges to production in the intensive 
meat rabbit industry. For the reasons given above, rabbit TLR2 may be an important candidate gene for resistance 
to a variety of economically important infectious bacterial diseases. Studies on TLR2 polymorphism in rabbits have, 
therefore, potential for improving disease control in rabbits via controlled breeding for disease resistance.
concluSionS
Our work was aimed at identifying polymorphisms in the rabbit TLR2 gene and investigating how non-synonymous 
SNPs may influence the function of the predicted protein structure of this gene. We also examined structurally 
conserved domains in the predicted TLR2  proteins in different mammals and identified promising candidate 
polymorphisms for future association studies and signal transduction research. Finally, we characterised 11 SNPs and 
5 LRR conserved domains. From these data, we identified the locations of the SNPs in the predicted protein, which 
allowed us to infer which polymorphisms had potential biological significance. TLR2 could be an important candidate 
gene for resistance to infectious diseases in rabbits. Identification of the polymorphisms reported here increases the 
number of useful genetic markers for disease resistance mapping and association analyses. Future research will 
focus on using larger numbers of samples to verify the polymorphisms reported herein and conducting association 
studies on infectious disease resistance in rabbits.
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